NASDAQ: AQSTAquestive Therapeutics Inc Stock Ownership - Who owns Aquestive Therapeutics?
Insider buying vs selling
Have Aquestive Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Daniel Barber | CEO;Pres | 2026-08-17 | 25,000 | $4.29 | $107.18kSell |
| Sherry Korczynski | CCO | 2026-08-14 | 2,714 | $4.25 | $11.53kSell |
| Daniel Barber | CEO;Pres | 2026-07-16 | 20,369 | $4.00 | $81.52kSell |
| Daniel Barber | CEO;Pres | 2026-07-15 | 4,631 | $4.03 | $18.68kSell |
| Julie Krop | Director | 2026-06-23 | 25,000 | $0.71 | $17.83kBuy |
| Julie Krop | Director | 2026-06-23 | 25,000 | $5.02 | $125.40kSell |
| Daniel Barber | President and CEO | 2026-06-15 | 25,000 | $4.16 | $104.00kSell |
| Melina Cioffi | SVP Regulatory Affairs | 2026-05-15 | 1,667 | $4.17 | $6.95kSell |
| Daniel Barber | President and CEO | 2026-05-15 | 8,257 | $4.29 | $35.41kSell |
| Lori J. Braender | Corporate Secretary | 2026-05-07 | 135,690 | $4.23 | $573.97kSell |
AQST insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AQST insiders and whales buy or sell their stock.
AQST Shareholders
What type of owners hold Aquestive Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Douglas K. Bratton | 1.56% | 1,963,890 | $10.49M | Insider |
| Alexander Mark Schobel | 0.78% | 984,476 | $5.26M | Insider |
| Keith J. Kendall | 0.51% | 639,149 | $3.41M | Insider |
| Daniel Barber | 0.47% | 585,574 | $3.13M | Insider |
| Stephen Wargacki | 0.27% | 343,552 | $1.83M | Insider |
| A. Ernest Toth Jr. | 0.23% | 283,460 | $1.51M | Insider |
| Carl N. Kraus | 0.23% | 282,475 | $1.51M | Insider |
| Peter E. Boyd | 0.22% | 281,731 | $1.50M | Insider |
| Melina Cioffi | 0.22% | 273,200 | $1.46M | Insider |
| Sherry Korczynski | 0.19% | 235,689 | $1.26M | Insider |
AQST vs Pharmaceutical Stocks
Aquestive Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.